SunMax Biotechnology Co. Ltd.(TW:4728)
NT$388.000.00 (0.00%)
TW:4728
SunMax Biotechnology Co. Ltd. Revenue
NT$388.00
At close:0.00 (0.00%)
SunMax Biotechnology Co. Ltd. (4728) Revenue
SunMax Biotechnology Co. Ltd. Revenue
SunMax Biotechnology Co. Ltd. had a revenue of 618.26M in the quarter ending Jun 30, 2026, with 9.46%. This bring the company's revenue in the last twelve months to 2.19B, Increased 7.76%. In the fiscal year ending Dec 31, 2025, SunMax Biotechnology Co. Ltd. had annual revenue of 2.03B with 11.45% growth.
- Revenue (ttm)
- 2.19B
- Revenue Growth
- 12.50%
- P/S Ratio
- 10.43
- Revenue/Employee
- TWD 67,538,800
- Employees
- 30
- Market Cap
- TWD 21.13B
Revenue Chart
SunMax Biotechnology Co. Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.03B | 208.15M | 11.45% |
| Dec 31, 2024 | 1.82B | 129.03M | 7.64% |
| Dec 31, 2023 | 1.69B | 288.91M | 20.64% |
| Dec 31, 2022 | 1.40B | 364.42M | 35.19% |
| Dec 31, 2021 | 1.04B | 179.81M | 21.01% |
| Dec 31, 2020 | 855.85M | 261.71M | 44.05% |
| Dec 31, 2019 | 594.14M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.